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A B S T R A C T
Introduction: The poverty, poor environmental living conditions and poor health standards experienced by Aboriginal Australians 
in some communities in rural and remote Australia have been described recently as ‘fourth world’. For more than a century 
Aboriginal people have suffered the effects of dispossession of their land; destruction of their traditional culture and values; and 
exposure to infectious diseases, alcohol and the Western diet that is high in fat and sugar. Collectively these factors have 
contributed to the prevalence of chronic disease that afflicts Aboriginal people.  In particular, renal disease has emerged during the 
last decade as a major contemporary health problem for Aboriginal Australians. According to the latest age- and sex-adjusted 
figures, Aboriginal people now have approximately nine-fold the risk of non-Aboriginal Australians of developing end-stage renal 
disease. In parts of Australia's Northern Territory, where Aboriginal people represent over 20% of the Territory's population, the 
rates of end-stage renal disease have been described as ‘epidemic’, reaching 2700 per million in the Tiwi Islands.  In response to a 
request from the Umoona Tjutagku Health Service in mid 1997, the Renal Unit at Flinders Medical Centre, Adelaide, South 
Australia, formed a partnership with the health service to conduct a renal-disease screening program for adult members of the 
Umoona Community at Coober Pedy, a town 850 kilometres north of Adelaide. The partnership was later expanded to include 
screening for children (conducted by the Renal Unit at the Women’s and Children’s Hospital, Adelaide, South Australia). The 
community named the program 'The Umoona Kidney Project’.  The Umoona community had recently experienced the dislocation 
of a number of its older people who suffered from advanced renal disease and were undergoing dialysis in a variety of centres in 
South Australia and the Northern Territory. As a result, the community had suffered social trauma. Consistent with the 
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community’s overall holistic approach to healthcare, the community wanted the renal program to provide a focus for community 
awareness of and knowledge about chronic disease, as well as to complement existing health programs. 
Objectives: The study objectives were to identify the prevalence of risk factors for renal disease, notably albuminuria, in adults 
from a remote Aboriginal community, and to examine the association of albuminuria with other risk factors; to empower 
Aboriginal health workers to self-manage a sustainable, community-controlled renal health program; and to assess the reliability 
and cultural acceptability of point-of-care technology for detecting renal disease.
Method: The study was a three-year cross-sectional voluntary adult screening program (The Umoona Kidney Project). The study 
was performed as a partnership between the Flinders Medical Centre Renal Unit and the Umoona Tjutagku Health Service, and it 
involved nephrologists, medical scientists, Aboriginal health workers and clinical nurses. Setting: Umoona Tjutagku Health 
Service, 850 km north of Adelaide.  Participants: 158 adult members of the Umoona community: 58 males (37%; mean age = 43.8 
years, range 23-78) and 100 females (63%; mean age = 39.6 years, range 18-72).   Main outcome measures: First morning urine 
albumin : creatinine ratio measured by the Bayer DCA 2000 point-of-care analyser machine (Bayer Australia, Melbourne, 
Australia); lying and standing blood pressure; random blood glucose; body mass index; urinalysis. 
Results: The study found that of screened adults, 29/149 (19%, 95% C.I. 13%-27%) had persistent microalbuminuria and 13/149 
(9%, 95% C.I. 4%-14%) had persistent macroalbuminuria; 62/148 participants (42%, 95% C.I. 34%-50%) had overt hypertension; 
35/145 participants (24%, 95% C.I. 17%-32%) had diabetes; 3 participants were newly diagnosed as having non-insulin dependent 
diabetes; 96/148 participants (65%, 95% C.I. 57%-73%) were either overweight or obese. Strong correlation was observed between 
the progression of albuminuria and age, all blood pressure categories, blood glucose, body mass index and an increasing number of 
risk factors. 
Conclusions: The Umoona Kidney Project identified a significant community burden of previously unknown incipient and 
established renal disease that required addressing via clinical- and community-based interventions. The DCA 2000 was a reliable 
instrument for detecting albuminuria on-site in the remote clinical location and was well accepted by Aboriginal health workers 
and community participants.
Key words: Aboriginal health, albuminuria, renal disease.
INTRODUCTION
The poverty, poor environmental living conditions 
and poor health standards experienced by Aboriginal 
Australians in some communities in rural and remote 
Australia have been described recently as ‘fourth 
world’1. For more than a century Aboriginal people 
have suffered the effects of dispossession of their 
land; destruction of their traditional culture and 
values; and exposure to infectious diseases, alcohol 
and the Western diet that is high in fat and sugar. 
Collectively these factors have contributed to the 
prevalence of chronic disease that afflicts Aboriginal people. 
In particular, renal disease has emerged during the last 
decade as a major contemporary health problem for 
Aboriginal Australians. 
Several recent studies have highlighted the cultural and 
financial burden of this disease2-5. According to the latest 
age- and sex-adjusted figures, Aboriginal people now have 
approximately nine-fold the risk of non-Aboriginal 
Australians of developing end-stage renal disease6. In parts 
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of Australia's Northern Territory, where Aboriginal 
people represent over 20% of the Territory's 
population, the rates of end-stage renal disease have 
been described as ‘epidemic’, reaching 2700 per 
million in the Tiwi Islands7-8. Calls for the 
introduction of community-based screening programs 
for the early detection of renal disease have been 
widely promulgated 4-9.
In response to a request from the Umoona Tjutagku 
Health Service in mid 1997, the Renal Unit at 
Flinders Medical Centre, Adelaide, South Australia, 
formed a partnership with the health service to 
conduct a renal-disease screening program for adult 
members of the Umoona Community at Coober Pedy, 
a town 850 km north of Adelaide. The partnership 
was later expanded to include screening for children 
(conducted by the Renal Unit at the Women’s and 
Children’s Hospital, Adelaide, South Australia). The 
community named the program 'The Umoona Kidney 
Project’. 
The Umoona community had recently experienced 
the dislocation of a number of its older people who 
suffered from advanced renal disease and were 
undergoing dialysis in a variety of centres in South 
Australia and the Northern Territory. As a result, the 
community had suffered social trauma. Consistent 
with the community’s overall holistic approach to 
healthcare, the community wanted the renal program 
to provide a focus for community awareness of and 
knowledge about chronic disease, as well as to 
complement existing health programs. 
Pathologically, end-stage renal disease among 
Aboriginal people has been shown to be mainly 
glomerular in nature10. Renal biopsy studies indicate 
Aboriginal people have increased rates of 
glomerulomegaly, mesangiocapillary glomerulonephritis, 
diabetic nephropathy and non-IgA proliferative 
glomerulonephritis, compared with the non-Aboriginal 
population11. Glomerular damage is characterised by 
albuminuria10. As an integral part of The Umoona Kidney 
Project, the point-of-care DCA 2000 machine (Bayer 
Australia, Melbourne, Australia) was used for the first time 
in an Aboriginal community to detect albuminuria12. The 
small, portable DCA 2000 (dimensions, 24 x24 x27 cm; 5 
kg) measures the urine albumin : creatinine ratio (ACR) on 
40 mL urine with an on-site result available in 7 min. Prior 
to its use in the field, the DCA 2000 underwent a full 
scientific evaluation13.
This article describes the results of the adult screening 
program from 1 June 1998 to 31 December 2000, examines 
the associations between albuminuria and other risk factors 
for renal disease, and discusses the application of the DCA 
2000 point-of-care technology for renal screening in the 
remote clinical setting.
Method
Community consultation, program ownership and direction
Prior to commencing the adult screening program, clinical 
and scientific staff from the Renal Unit at Flinders Medical 
Centre undertook 6 months of community consultation with 
the Board of the Umoona Tjutagku Health Service and 
Umoona community members. This consultation was 
facilitated by a series of open community forums held during 
field visits to Coober Pedy. At these meetings the 
community expressed its concerns about renal disease and its 
aspirations for the program, resulting in the clearly defined 
aims and objectives of The Umoona Kidney Project. These 
aims and objectives included the early detection of renal 
disease among community members by the implementation 
of a renal screening program. Ownership of the program 
resided with the community and the Flinders Medical Centre 
renal team was responsible to, and directed by, the Board of 
the Umoona Tjutagku Health Service.
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Personnel
The Flinders Medical Centre renal team consisted of 
a scientist-program manager, two nephrologists, a 
data manager and a nutritionist. The renal team 
conducted 20 field visits to the community during the 
project's three-year duration. The Umoona health 
team consisted of  Aboriginal health workers (with 
four health workers working on the program across 
its duration), supported by a clinical nurse. The local 
medical officer at the Coober Pedy Hospital, the 
town's general practitioner and nursing staff at the 
hospital also assisted the program
Participants
The adult screening program was open to community 
members who were 18 years or older, and 
participation was entirely voluntary. Each of the 158 
participants gave prior, signed and informed consent. 
Screening
At the request of the community, screening was 
conducted at the health service clinic and began in 
June 1998. The Aboriginal health workers recorded 
each participant's height and weight (for calculation 
of body mass index [BMI]) and measured their blood 
glucose using a glucose meter (Medisense; Abbott 
Diagnostics, Sydney, NSW, Australia). Following 
these test, participants underwent an initial 
consultation with one of the visiting nephrologists, 
during which family and personal medical histories 
were recorded and a medical examination took place, 
which included lying and standing blood pressure 
(BP) measurement. 
Each participant brought with them a first-morning
urine specimen collected in a 75mL sterile container. 
The urine was tested qualitatively using Multistix 
(Bayer Australia) dipsticks on the Clinitek 50 Urine 
Analyser (Bayer Australia) for the presence of 
protein, glucose, blood, nitrites and leucocytes. 
Provided the urine specimen was negative for blood, 
leucocytes and nitrites, the urine was tested on-site with the 
DCA 2000 for urine ACR. The urine ACR result was handed 
to the nephrologist during the initial consultation. The 
nephrologist then provided the participant with immediate 
feedback on his or her overall risk-factor profile.
Each participant’s baseline screening data was recorded on a 
single-page proforma and the information was transferred 
electronically on-site to a patient data-management program 
(designed using Microsoft Access software).
Risk factor assessment
The following parameters were considered risk factors for 
renal disease: 
• Persistent hypertension (>140/>90 mmHg on at least 
two separate occasions)
• Random blood glucose greater than 11.1 mmol/L (at 
least twice) 
• Persistent albuminuria (urine ACR >3.4 mg/mmol on a 
first morning specimen14 on at least two separate 
occasions, with the specimens being negative for 
leucocytes and nitrites)
• Obesity (BMI >30 kg/m2) 
• ‘Positive’ family or personal medical history, notably a 
current smoker or consumer of amounts of alcohol 
greater than 50 g per day for males or greater than 20 g 
per day for females 
• A history of recurrent skin infections. 
Repeat measurements necessary to confirm persistent 
hypertension or albuminuria were conducted either by the 
Umoona health team between field visits, by the renal team, 
or by the nephrologist at the next available field visit. The 
use of first morning specimens for measuring urine ACR 
was considered preferable to a random sample, which is 
subject to the potential false-positive effects of posture and 
exercise and has greater within-person biological variation 
15-18.
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Following initial clinical review, an action plan was 
developed for each participant and recorded 
electronically. This action plan detailed further 
investigations to be performed (notably repeat BP and 
urine ACR tests), as well as other clinical information 
to be collected prior to the next field visit (eg current 
medications).
Ethics approval
Ethics clearance to conduct The Umoona Kidney 
Project was obtained from the Aboriginal Health 
Research Ethics Committee of South Australia and 




By January 2001, 158 adults (approximately 65% of 
the community’s total adult population) had 
undergone a complete screening assessment. Those 
screened were 58 males (37%; mean age = 43.8 years, range 
23-78) and 100 females (63%; mean age = 39.6 years, range 
18-72 years).
Overview of screening results
During the three-year screening program, the team's 
nephrologists conducted 328 patient encounters: 82 people 
were seen once, 14 people were seen twice, 66 people were 
seen three times and five people were seen four times. A 
total of 232 on-site urine ACR measurements were 
performed.
The overall mean (± standard error) of measurements 
conducted during screening is shown for all adults, as well as 
by gender (Table 1). Diastolic and systolic BP (lying and 
standing) and weight were higher in males than in females (p
< 0.03 in all cases, unpaired t-test). Blood glucose levels 
were higher in female participants than in males but the
trend was not significant.
Table 1: Summary of measurements conducted during screening of adult population*
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Prevalence of risk factors
The overall prevalence of individual risk factors found during community screening is shown (Figure 1).
Figure 1: Overall community prevalence of risk factors split by gender. The male : female split shown for each risk factor reflects 
the relative contribution of gender to the total % of people screened who had positive risk.
Greater than 25% of all adults screened (n = 42/149) had 
previously undiagnosed persistent microalbuminuria (urine 
ACR between 3.4 and 34 mg/mol) or macroalbuminuria 
(>34 mg/mmol). The mean, standard error and range of ACR 
values found was 16.0 ± 1.8 mg/mmol (3.6-33.1  mg/mmol) 
for the microalbuminuric group and 114 ± 24 mg/mmol 
(range 37-349 mg/mmol) for the macroalbuminuric group. 
Hypertension was found in greater than 40% of the 
participants (n = 62/148) with a significantly higher rate 
observed in males (59%) compared with females (32%; p = 
0.02, Chi-squared trend analysis). Fifty-eight per cent of 
participants with hypertension (n = 86/148) were 
undiagnosed prior to screening. Approximately 25% of all 
people screened (n = 35/145) had non-insulin dependent 
(type 2) diabetes mellitus (as assessed by personal history or 
random blood glucose), and greater than 50% of participants 
screened also had a positive family history for this condition. 
Three participants were discovered to have non-insulin 
dependent diabetes mellitus during screening. Two-thirds of 
the population surveyed (n = 96/148) was either obese 
(BMI > 30 = kg/m2) or overweight (BMI between 25 and 30 
kg/m2). Rates of alcohol and tobacco consumption were 
high, with greater than 50% of all males drinking to excess 
and smoking tobacco. 
Association between albuminuria and co-existing risk 
factors
As shown (Table 2), the progression of albuminuria was 
significantly associated with the following continuous 
variables: age, diastolic and systolic BP in both lying and 
standing positions, and blood glucose (p < 0.01 in all cases, 
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ANOVA). These differences remained significant when 
controlling for age and sex. 
Table 2: The association between measured risk factors and ACR category
In addition, the categoric variables hypertension, diabetes 
and obesity all showed strong associations with stratified 
ACR levels (p<0.02 in all cases, logistic regression analysis, 
data adjusted for age and sex). An association was also 
observed between albuminuria and an increasing number of 
these coexisting categoric risk factors (Figure 2). The 
proportion of people whose ACR was normal decreased as 
the number of coexisting risk factors increased. The risk of 
microalbuminuria was significantly increased in the presence 
of one or more risk predictors while the risk of 
macroalbuminuria increased significantly in the presence of 
two or more coexisting risk factors (Chi-squared trend 
analysis). 
Figure 2: Association between albuminuria and an increased number of coexisting risk factors
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Other observations during screening
The screening program also identified non-renal conditions 
including heart failure (n = 1), angina/myocardial infarction 
(n = 1), hepatitis B (n = 1), pregnancy (n = 1), bronchiectasis 
(n = 1), active scabies (n = 1), chronic leg ulcers (n = 1) and 
sub-mandibular abscess (n = 1).
Discussion
This article details the results of the first comprehensive 
screening program for renal disease undertaken in a remote 
Aboriginal community in South Australia, using a point-of-
care instrument (the Bayer DCA 2000) as the primary 
screening tool for quantifying microalbuminuria. The 
program has identified a significant burden of incipient and 
established renal disease among adult members of this rural 
Aboriginal community. The high rates of microalbuminuria 
(n = 29; 19%) and macroalbuminuria (n = 13; 9%) found in 
this study are the first reported for an Aboriginal community 
in South Australia. They are generally consistent with rates 
reported in Aboriginal communities in other parts of 
Australia. For example, a study of approximately 
1100 Aboriginal adults (> 15 years) from eight communities 
in central Australia, the Kimberley and Cape York areas in 
northern Australia reported microalbuminuria rates of 22% 
for men and 27% for women, while the prevalence of 
macroalbuminuria was 10% for men and 13.5% for 
women19. Microalbuminuria rates of 27% have been 
observed in a large northern Australian community of 
approximately 700 people5,20. 
Albuminuria, if left untreated, may progress from 
microalbuminuria to macroalbuminuria and renal 
insufficiency arising from overt albuminuria10,21. Screening 
for albuminuria using a simple non-invasive urine test, such 
as urine ACR, is therefore critical because the earlier 
albuminuria is detected the greater the chance of modifying 
the progression of the disease. All community members 
identified with incipient or overt renal disease in The 
Umoona Kidney Project were offered and accepted the 
opportunity to participate in tailored clinical and community-
based intervention programs that were aimed not only at 
reducing the burden of renal disease, but also the high rates 
of associated hypertension, diabetes and obesity found in this 
community22,23. The clustering of these risk factors with 
albuminuria is part of the overall metabolic syndrome, and 
all factors need to be addressed concurrently if an impact is 
to be made on reducing the chronic disease burden of the 
community.
Indeed, the screening phase of The Umoona Kidney Project 
was conducted as part of a broad, family-orientated holistic 
approach to addressing chronic disease within the Aboriginal 
community setting. Community awareness programs about 
renal health, the importance of good nutrition and exercise, 
and strategies to reduce alcohol and tobacco consumption 
were conducted at different levels for both Aboriginal Health 
Workers and adults and children in the community23. The 
Flinders and Women's and Children's renal teams also 
formed partnerships with a number of community groups 
including the Umoona Aged Care Services, the Aboriginal 
Meals Program, the Coober Pedy Area School and the Tjapa 
Tjuta Child Care Centre. At the request of the Aboriginal 
health-worker team, a nutrition training program was 
developed by the team's nutritionists specifically for the 
health workers; the content, level, timing and length of this 
training program determined by the health workers 
themselves23. 
The point-of-care DCA 2000 instrument was the cornerstone 
of the renal screening program. It proved robust and reliable 
in a remote clinical setting and demonstrated sound 
analytical performance characteristics during 30 months of 
regular field use12. The purchase price of the DCA at 
approximately $AU6500 and the cost of ACR reagent 
cartridges at approximately $AU9 each, means the DCA 
point-of-care technology is a cost competitive, practical 
alternative to the pathology laboratory for remote 
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communities. The ability of the DCA 2000 to generate an 
on-site result in 7 min provided an improved service for 
community members and greater client satisfaction, because 
results could be discussed with the doctor during the 
consultation. In the early stages of the screening program, a 
scientist or technician from the visiting renal team operated 
the DCA to perform the urine ACR tests. However, 
following an education and training program in September 
1999, Umoona’s Aboriginal health-worker team assumed 
full responsibility for performing urine ACR tests in the 
latter stages of the program. By performing the tests 
themselves, health workers have been empowered to take 
greater responsibility for renal screening in their community, 
while sustainability and community control and ownership 
of the program has been ensured. The Umoona Kidney 
Project was formally handed over to the community in 
December 2000, with the Flinders renal team still providing 
clinical, scientific, technical and data management support 
when appropriate.
Conclusion
The practicability, clinical usefulness and cultural 
appropriateness of using point-of-care technology in the 
remote Aboriginal health setting has been clearly 
demonstrated in The Umoona Kidney Project, and further 
opportunities exist to broaden the scope and application of 
point-of-care instruments in community-based screening and 
management programs.
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